Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.

Dosage Regimen: Individualization

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...

Drug Dosing: Geriatric Patients

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...

Dosage Regimens: Designs and Approaches

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Faecal Bacterial and Short-Chain Fatty Acid Profiles in Response to 48 h FODMAP Intervention Prior to Endurance Exercise.

Nutrients·2026

Same author

Negative Effects of COVID-19 in Hypertensive and Diabetic Patients: A Pre-Post Study.

Health science reports·2026

Same author

Slippery organogel coatings on nitric oxide-releasing polymers for dual-action antibiofouling properties.

Journal of colloid and interface science·2026

Same author

Surface engineering <i>'liquid-like'</i> solid surfaces with nitric oxide releasing polymers to combat biofouling.

Chemical engineering journal (Lausanne, Switzerland : 1996)·2026

Same author

Higher education student engagement in learning activities: Clarifying concepts and introducing a short-scale.

PloS one·2026

Same author

Correction: The impact of 48 h high carbohydrate diets with high and low FODMAP content on gastrointestinal status and symptoms in response to endurance exercise, and subsequent endurance performance.

Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme·2025

Search research articles

Related Experiment Video

Updated: Nov 5, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Patient Assistance Programs and Technology in Medication Adherence.

Carlos Colon¹, Paulette Salas¹, Militza Díaz¹

¹Nova Southeastern University College of Pharmacy.

Innovations in Pharmacy

|May 19, 2021

Summary

This summary is machine-generated.

Patient assistance programs and technology significantly improve medication adherence for chronic disease patients. These tools help overcome barriers like financial hardship and complex treatment plans.

Keywords:

medication adherence patient assistant programs pharmacy technology

More Related Videos

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

Related Experiment Videos

Last Updated: Nov 5, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

Area of Science:

Health Services Research
Pharmacoeconomics
Digital Health

Background:

Patient assistance programs (PAPs) offer medication management and counseling, crucial for complex chronic disease therapies.
Technology integration is increasingly vital for enhancing patient adherence to treatment regimens.

Purpose of the Study:

To identify barriers impacting medication adherence.
To review the influence of PAPs and technology on medication adherence.

Main Methods:

Conducted a literature search in PubMed/MEDLINE and EBSCOhost.
Included systematic reviews, experimental, quasi-experimental, and observational studies from the last 15 years.
Searched terms: patient assistance program, pharmacist role, technology, adherence, compliance, income, health.

Main Results:

Lower adherence correlated with male sex, chronic diseases, negative treatment expectations, polypharmacy, financial hardship, and lower education.
PAPs and technology, such as mobile applications, demonstrated improved medication adherence.

Conclusions:

PAPs are essential resources for enhancing medication adherence.
Technological tools, including mobile applications, are vital for improving patient adherence to medications.